What is paroxetine used for? Paroxetine is commonly used for the following conditions. Paroxetine is an antidepressant that belongs to a group of medicines called selective serotonin reuptake ...

Paroxetine is prescribed to treat multiple conditions including depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder ...

Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with antidepressants have less severe depression-like symptoms after the ...

The recent approval by the Food and Drug Administration (FDA) of paroxetine (Brisdelle, Noven) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause was distinctive ...

From the multiple classes of pharmacologically active compounds identified from the screen, we have focused our subsequent studies on the clinically used antidepressant compound paroxetine.

The widely prescribed antidepressant paroxetine -- sold under the names Paxil, Aropax and Seroxat -- has been found to be neither a safe nor effective treatment for depression in adolescents ...

The European Court of Justice's ruling in Paroxetine, handed down in record time just before Brexit, confirms the narrow interpretation of restrictions by object given in other recent cases.

In a trial screening of 446 drugs in wide circulation, the new assay singled out the popular antidepressant paroxetine (better known by its commercial name, Paxil) as having a weak estrogenic ...

February 9, 2010 — Paroxetine and fluoxetine should not be prescribed for depression or hot flashes in women who have had breast cancer and are now taking tamoxifen to prevent a recurrence.

As such, the purpose of this study was to evaluate differential rates of adherence between paroxetine controlled release (CR) and paroxetine immediate release (IR) in the treatment of anxiety ...

Patients who started oxycodone while taking fluoxetine or paroxetine were at increased risk for opioid overdose compared with those who were taking other selective serotonin reuptake inhibitors ...

Taking into account previous methodological criticisms and considering the molecular target of SSRIs, we have tested whether paroxetine dose escalation increases SERT occupancy and improves ...